Scientists test drug mix in healthy volunteers
NCT ID NCT05906836
Summary
This study aimed to understand how a single dose of the cancer medication selpercatinib changes the amount of the cholesterol-lowering drug rosuvastatin in a person's bloodstream. It involved 28 healthy adult participants and measured drug levels and safety over about a month. The goal was to gather information for future use, not to treat any disease.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Labcorp Clinical Research LP
Dallas, Texas, 75247, United States
Conditions
Explore the condition pages connected to this study.